Insights

The EU AI Act, effective August 1, 2024, establishes stringent standards for AI risk management, transparency, and oversight. In response, regular training and policy updates are crucial for ensuring compliance and maintaining a competitive edge. This alert explores the Act’s key elements and their impact on EU businesses, highlighting the importance of risk assessment, data management updates, and dynamic strategies.

The Association of Certified Fraud Examiners ("ACFE"), a global anti-fraud organization, has recently published its 2024 Occupational Fraud Report (the "Report"). Drawing from data spanning 138 countries and 22 industry sectors, the report reveals staggering losses exceeding USD 31.1 billion due to occupational fraud.

Notable developments in data protection in Türkiye as the bill, featuring key amendments to the Personal Data Protection Law, has been given the green light in the Turkish Grand National Assembly. Pending the President's approval, the changes are set to take effect upon publication in the Official Gazette.

Explore the EU antitrust impact on pharmaceuticals (2018-2022). The recent report underscores the pivotal role of antitrust measures—promoting fair medicine prices, addressing anticompetitive practices, and shaping the future of pharmaceutical enforcement in Europe. In times of robust enforcement in both the EU and Türkiye, strategic compliance becomes imperative, providing pharmaceutical companies with a competitive edge.

Binance, ABD yasalarını ihlal ettiği suçlamalarıyla ilgili yürütülen soruşturma sonucunda, rekor miktarda ceza ödemek ve ABD pazarından çekilmek zorunda kaldı. Yaşanan gelişmelerin, sektördeki diğer kuruluşları, uyum programlarını entegre etme konusunda teşvik etmesi beklenirken, uygulanan yaptırımların da sektörde bir dönüm noktası olduğu değerlendiriliyor.